In Brief This Week: Quest Diagnostics; Rosetta Genomics; GeneNews | GenomeWeb

By a GenomeWeb staff reporter



NEW YORK (GenomeWeb News) – Quest Diagnostics this week said that its Simplexa Flu A/B & RSV Direct test has received the CE Mark and has been launched in Europe. The molecular test, developed by the firm's Focus Diagnostics business, runs on the 3M Integrated Cycler. The test uses a proprietary technique to eliminate nucleic-acid sample extraction, leading to faster results reporting, said Quest.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.